• Cellebrite DI Ltd CLBT.OQ reported quarterly adjusted earnings of 10 cents​​ per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of 11 cents. The mean expectation of eight analysts for the quarter was for earnings of 10 cents per share. Wall Street expected results to range from 8 cents to 11 cents per share.

• Revenue rose 17.2% to $109.05 million from a year ago; analysts expected $107.18 million.

• Cellebrite DI Ltd's reported EPS for the quarter was 8 cents​.

• The company reported quarterly net income of $19.27 million.

• Cellebrite DI Ltd shares had risen by 13.1% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the software peer group is also "buy"

Wall Street's median 12-month price target for Cellebrite DI Ltd is $24.00

This summary was machine generated from LSEG data February 13 at 02:30 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)